Cerebrovascular dynamics and vascular endothelial growth factor in acute mountain sickness

Wilderness and Environmental Medicine

Volumn 17, Issue 1, 2006, Pages 1-7

  Palma, Joseph ^a   Macedonia, Christian ^b   Deuster, Patricia ^a,b   Olsen, Cara ^a   Mozayeni, B Robert ^c   Crutchfield, Kevin E ^b,c,d  

^a Uniformed Services University of the Health Sciences   (United States)

^b UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

^c New Health Sciences Inc   (United States)

^d New Health Sciences Inc   (United States)

Author keywords

Acute mountain sickness; Altitude; Blood brain barrier; Dynamic vascular analysis; Endothelial dysfunction; Transcranial Doppler ultrasound; Vascular endothelial growth factor

Indexed keywords

VASCULOTROPIN;

ALTITUDE; ALTITUDE DISEASE; ANALYSIS; ARTICLE; BLOOD BRAIN BARRIER; BLOOD FLOW VELOCITY; BLOOD LEVEL; BLOOD VESSEL CAPACITANCE; BLOOD VESSEL PERMEABILITY; BRAIN BLOOD FLOW; BRAIN BLOOD VESSEL; BRAIN EDEMA; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEVICE; DOPPLER ECHOGRAPHY; DYNAMIC VASCULAR ANALYSIS; HUMAN; HUMAN EXPERIMENT; HYPOCAPNIA; HYPOXEMIA; LAKE LOUISE SCORE; MALE; NORMAL HUMAN; PATHOPHYSIOLOGY; PULSATILE FLOW; SCORING SYSTEM; SEA LEVEL; SINGLE BLIND PROCEDURE; SPIELBERGER 1 SCORE; SUBJECTIVE EXERCISE EXPERIENCES SCALE; SYMPTOM CHECKLIST 90; SYMPTOMATOLOGY; VASCULAR ENDOTHELIUM;

EID: 33644871246     PISSN: 10806032     EISSN: None     Source Type: Journal    
DOI: 10.1580/1080-6032(2006)17[1:CDAVEG]2.0.CO;2     Document Type: Article

References (37)

1. West JB. Oxygen enrichment of room air to improve well-being and productivity at high altitude. Int J Occup Environ Health. 1999;5:187-193.
2. Burtscher M. High altitude headache: epidemiology, pathophysiology, therapy and prophylaxis. Wien Klin Wochenschr. 1999;111:830-836.
3. Schoch HJ, Fischer S, Marti HH. Hypoxia-induced vascular endothelial growth factor expression causes vascular leakage in the brain. Brain. 2002;125(pt 11):2549-2557.
4. Appenzeller O, Minko T, Pozharov V, et al. Gene expression in the Andes; relevance to neurology at sea level. J Neurol Sci. 2003;207:37-41.
5. Maloney J, Wang D, Duncan T, Voelkel N, Ruoss S. Plasma vascular endothelial growth factor in acute mountain sickness. Chest. 2000;118:47-52.
6. Mentzer RM, Rubio R, Berne RM. Release of adenosine by hypoxic canine tissue and its possible role in pulmonary circulation. Am J Physiol. 1975;229:1625-1631.
7. Jensen JB, Wright AD, Lassen NA, et al. Cerebral blood flow in acute mountain sickness. J Appl Physiol. 1990;69:430-433.
8. Yang YB, Sun B, Yang Z, Wang J, Pong Y. Effects of acute hypoxia on intracranial dynamics in unanesthetized goats. J Appl Physiol. 1993;74:2067-2071.
9. Berre J, Vachiery JL, Moraine JJ, Naeije R. Cerebral blood flow velocity responses to hypoxia in subjects who are susceptible to high-altitude pulmonary oedema. Eur J Appl Physiol. 1999;80:260-263.
10. Ter MA, Beydon L, Ursino M, Gardette B, Gortan C, Richalet JP. Doppler study of middle cerebral artery blood flow velocity and cerebral autoregulation during a simulated ascent of Mount Everest. Wilderness Environ Med. 2001;12:175-183.
11. Otis SM, Rossman ME, Schneider PA, Rush MP, Ringelstein EB. Relationship of cerebral blood flow regulation to acute mountain sickness. J Ultrasound Med. 1989;8:143-148.
12. Hackett PH. The cerebral etiology of high-altitude cerebral edema and acute mountain sickness. Wilderness Environ Med. 1999;10:97-109.
13. Crutchfield KE, Razumovsky AY, Tegeler CH, Mozayeni BR. Differentiating vascular pathophysiological states by objective analysis of flow dynamics. J Neuroimaging. 2004;14:97-107.
14. Speilberger CD, Gorsuch RL. Manual for the State-Trait Anxiety Inventory (STAI). Palo Alto, Calif: Consulting Psychologists Press; 1970.
15. Hardt J, Gerbershagen HU, Franke P. The Symptom Checklist SCL-90-R: its use and characteristics in chronic pain patients. Eur J Pain. 2002;4:137-148.
16. Savourey G, Guinet A, Besnard Y, Garcia N, Hanniquet A, Bittel J. Are the laboratory and field conditions observations of acute mountain sickness related? Aviat Space Environ Med. 1997;68:895-899.
17. Kao WF, Kuo CC, Hsu TF, et al. Acute mountain sickness in Jade Mountain climbers of Taiwan. Aviat Space Environ Med. 2002;73:359-362.
18. Aaslid R, Markwalder TM, Nornes H. Noninvasive transcranial Doppler ultrasound recording of flow velocity in basal cerebral arteries. J Neurosurg. 1982;57:769-774.
19. Baumgartner RW, Bartsch P, Maggiorini M, Waber U, Oelz O. Enhanced cerebral blood flow in acute mountain sickness. Aviat Space Environ Med. 1994;65:726-729.
20. Jansen GF, Krins A, Basnyat B. Cerebral vasomotor reactivity at high altitude in humans. J Appl Physiol. 2003;86:681-686.
21. Huang SY, Sun S, Droma T, et al. Internal carotid arterial flow velocity during exercise in Tibetan and Han residents of Lhasa. J Appl Physiol. 2003;73:2638-2642.
22. Jensen JB, Sperling B, Severinghaus JW, Lassen NA. Augmented hypoxic cerebral vasodilation in men during 5 days at 3,810 m altitude. J Appl Physiol. 1996;80:1214-1218.
23. Lassen NA. Increase of cerebral blood flow at high altitude: its possible relation to AMS. Int J Sports Med. 1992;13(suppl 1):S47-S48.
24. Jansen GF, Krins A, Basnyat B, Bosch A, Odoom JA. Cerebral autoregulation in subjects adapted and not adapted to high altitude. Stroke. 2000;31:2314-2318.
25. Lui Y, Harder DR, Lombard JH. Interaction of myogenic mechanisms and hypoxic dilation in rat middle cerebral arteries. Am J Physiol Heart Circ Physiol. 2002;283:H2276-H2281.
26. Weiskopf RB, Gabel RA, Fencl V. Alkaline shift in lumbar and intracranial CSF in man after 5 days at high altitude. J Appl Physiol. 1976;41:93-97.
27. Clench J, Ferrell RE, Schull WJ. Effect of chronic altitude hypoxia on hematologic and glycolytic parameters. Am J Physiol. 1982;242:R447-R451.
28. Schechter AN, Gladwin MT. Hemaglobin and the paracrine and endocrine functions of nitric oxide. N Engl J Med. 2003;348:1483-1485.
29. Abbott NJ. Astrocyte-endothelial interactions and blood-brain barrier permeability. J Anat. 2002;200:629-638.
30. Brown RC, Davis TP. Calcium modulation of adherens and tight junction function. Stroke. 2002;33:1706-1711.
31. Pachter JS, De Vries HE, Fabry Z. The blood-brain barrier and its role in immune privilege in the central nervous system. J Neuropathol Exp Neurol. 2003;62:593-604.
32. Van Hinsbergh VW, Van Nieuw Amerongen GP. Intracellular signalling involved in modulating human endothelial barrier function. J Anat. 2002;200:549-560.
33. Severinghaus JW. Hypothetical roles of angiogenesis, osmotic swelling, and ischemia in high-altitude cerebral edema. J Appl Physiol. 1995;79:375-379.
34. Walter R, Maggiorini M, Scherrer U, Contesse J, Reinhart WH. Effects of high-altitude exposure on vascular endothelial growth factor levels in man. Eur J Appl Physiol. 2001;85:113-117.
35. Maloney J, Wang D, Duncan T, Voelkel N, Ruoss S. Plasma vascular endothelial growth factor in acute mountain sickness. Chest. 2000;118:47-52.
36. Witt K, Marks KS, Hom S, Davis TP. Effects of hypoxia-reoxygenation on rat blood-barrier permeability and tight junction protein expression. Am J Physical Heart Circ Physiol 2003 Dec;285(6):H2820-31.
37. Golanov EV, Christensen JR, Reis DJ. Neurons of a limited subthalamic area mediate elevations in cortical cerebral blood flow evoked by hypoxia and excitation of neurons of the rostral ventrolateral medulla. J Neurosci. 2001;21:4032-4041.